Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
EDTXF Spectral Diagnostics	$0.60 -0.7%	$0.61	$0.32 ▼ $0.65	$170.97M	0.22	6,151 shs	19,000 shs
KIDS OrthoPediatrics	$22.47 +1.5%	$21.49	$19.52 ▼ $35.99	$545.68M	1.1	198,395 shs	90,392 shs
OFIX Orthofix Medical	$11.13 +0.6%	$11.61	$10.24 ▼ $20.73	$435.88M	0.8	288,046 shs	160,793 shs
WEDXF Westaim	$22.75 +0.4%	$23.03	$16.62 ▼ $25.98	$763.49M	0.2	2,725 shs	3,453 shs

Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
EDTXF Spectral Diagnostics	0.00%	-1.88%	-1.07%	+26.06%	+68.68%
KIDS OrthoPediatrics	0.00%	+5.12%	+6.02%	+3.05%	-27.09%
OFIX Orthofix Medical	0.00%	+0.32%	+1.41%	-22.53%	-17.65%
WEDXF Westaim	0.00%	+0.71%	-1.47%	+10.92%	+668.58%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
EDTXF Spectral Diagnostics	0.2403 of 5 stars	0.0	5.0	0.0	0.0	0.0	0.0	0.0
KIDS OrthoPediatrics	3.3354 of 5 stars	3.4	2.0	0.0	3.9	0.0	3.3	0.6
OFIX Orthofix Medical	2.6568 of 5 stars	3.5	2.0	0.0	0.0	0.0	3.3	1.3
WEDXF Westaim	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
EDTXF Spectral Diagnostics	0.00	N/A	N/A	N/A
KIDS OrthoPediatrics	2.83	Moderate Buy	$35.83	59.51% Upside
OFIX Orthofix Medical	3.00	Buy	$21.50	93.26% Upside
WEDXF Westaim	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest EDTXF, OFIX, KIDS, and WEDXF Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/23/2025	OFIX Orthofix Medical	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy	$16.00
6/6/2025	OFIX Orthofix Medical	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Perform ➝ Market Perform
5/8/2025	KIDS OrthoPediatrics	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$40.00 ➝ $30.00
5/8/2025	KIDS OrthoPediatrics	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$42.00 ➝ $42.00
4/11/2025	KIDS OrthoPediatrics	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$26.00 ➝ $24.00
4/9/2025	KIDS OrthoPediatrics	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$42.00 ➝ $42.00
4/7/2025	KIDS OrthoPediatrics	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$37.00

(Data available from 7/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
EDTXF Spectral Diagnostics	$1.67M	102.38	N/A	N/A	($0.07) per share	-8.55
KIDS OrthoPediatrics	$204.73M	2.67	N/A	N/A	$14.64 per share	1.53
OFIX Orthofix Medical	$799.49M	0.55	N/A	N/A	$13.07 per share	0.85
WEDXF Westaim	$17.04M	44.81	N/A	N/A	$23.28 per share	0.98

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
EDTXF Spectral Diagnostics	-$11.24M	-$0.07	N/A	∞	N/A	-1,078.10%	N/A	-336.97%	8/7/2025 (Estimated)
KIDS OrthoPediatrics	-$37.82M	-$1.75	N/A	N/A	N/A	-19.15%	-7.03%	-5.45%	8/4/2025 (Estimated)
OFIX Orthofix Medical	-$126M	-$3.69	N/A	N/A	N/A	-17.78%	-28.15%	-16.51%	8/5/2025 (Estimated)
WEDXF Westaim	-$16.18M	-$2.17	N/A	∞	N/A	-253.76%	-9.36%	-8.82%	8/12/2025 (Estimated)

Latest EDTXF, OFIX, KIDS, and WEDXF Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/4/2025	Q2 2025	KIDS OrthoPediatrics	-$0.17	N/A	N/A	N/A	$61.40 million	N/A
5/14/2025	Q1 2025	WEDXF Westaim	-$0.0316	-$0.34	-$0.3084	-$0.34	$1.34 million	($4.70) million
5/9/2025	Q1 2025	EDTXF Spectral Diagnostics	N/A	-$0.03	N/A	-$0.03	N/A	$0.40 million
5/7/2025	Q1 2025	KIDS OrthoPediatrics	-$0.26	-$0.39	-$0.13	-$0.46	$51.68 million	$52.41 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
EDTXF Spectral Diagnostics	N/A	N/A	N/A	N/A	N/A
KIDS OrthoPediatrics	N/A	N/A	N/A	N/A	N/A
OFIX Orthofix Medical	N/A	N/A	N/A	N/A	N/A
WEDXF Westaim	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
EDTXF Spectral Diagnostics	N/A	0.09	0.08
KIDS OrthoPediatrics	0.21	6.19	2.99
OFIX Orthofix Medical	0.38	2.71	1.50
WEDXF Westaim	N/A	11.40	11.40

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
EDTXF Spectral Diagnostics	N/A
KIDS OrthoPediatrics	69.05%
OFIX Orthofix Medical	89.76%
WEDXF Westaim	N/A

Insider Ownership

Company	Insider Ownership
EDTXF Spectral Diagnostics	1.50%
KIDS OrthoPediatrics	31.80%
OFIX Orthofix Medical	1.30%
WEDXF Westaim	4.21%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
EDTXF Spectral Diagnostics	29	285.52 million	281.24 million	Not Optionable
KIDS OrthoPediatrics	200	24.29 million	16.56 million	Optionable
OFIX Orthofix Medical	1,616	39.18 million	38.67 million	Optionable
WEDXF Westaim	7	33.56 million	32.14 million	Not Optionable

EDTXF, OFIX, KIDS, and WEDXF Headlines

Recent News About These Companies

Head to Head Survey: Hawkins (NASDAQ:HWKN) vs. Westaim (OTCMKTS:WEDXF)

June 27, 2025 | americanbankingnews.com

The Westaim Co. (OTCMKTS:WEDXF) Short Interest Update

June 15, 2025 | marketbeat.com

The Westaim Corporation Reports Q1 2025 Results

May 14, 2025 | businesswire.com

CC Capital and Westaim Complete Transaction, Creating Integrated Insurance and Asset Management Platform

April 3, 2025 | businesswire.com

Westaim Announces Receipt of Required Regulatory Approvals in Connection with CC Capital Transaction

March 27, 2025 | businesswire.com

The Westaim Corporation Announces Normal Course Issuer Bid

March 26, 2025 | businesswire.com

The Westaim Corporation Reports Q4 and Full Year 2024 Results and Update on Timing of Proposed Transactions with CC Capital

March 26, 2025 | businesswire.com

Westaim completes acquisition of ManhattanLife

February 6, 2025 | insurancebusinessmag.comI

Westaim: Transforming Into A Potential Long-Term Compounding Machine

January 30, 2025 | seekingalpha.com

The Westaim Corp WEDXD

January 14, 2025 | morningstar.comM

The Westaim Corporation Announces Completion of Arrangement

January 2, 2025 | businesswire.com

Westaim: Stocks Undervalued by Analyst Consensus on TSX-V (WED)

December 22, 2024 | theglobeandmail.com

The Westaim Corporation appoints CRO

December 6, 2024 | complianceweek.comC

The Westaim Corporation Files Management Information Circular for Special Shareholders Meeting and Encourages Shareholders to Access Meeting Materials Online

November 27, 2024 | newsfilecorp.comN

The Westaim Corporation Files Management Information Circular for Special Shareholders Meeting and Encourages Shareholders to Access Meeting Materials Online

November 27, 2024 | newsfilecorp.comN

CC Capital & Westaim partner on new integrated insurance and asset management platform

October 11, 2024 | reinsurancene.wsR

CC Capital and Westaim to create insurance and asset management platform

October 9, 2024 | pehub.com

Westaim Corporation: A Bargain In The Asset Management World

September 4, 2024 | seekingalpha.com

Westaim Corporation: Still Undervalued Based On NAV

July 19, 2024 | seekingalpha.com

The Westaim Corporation (WEDXF)

May 19, 2024 | finance.yahoo.com

Westaim: Q1 Earnings Snapshot

May 14, 2024 | timesunion.comT

Media Sentiment Over Time

EDTXF, OFIX, KIDS, and WEDXF Company Descriptions

Spectral Diagnostics OTCMKTS:EDTXF

$0.60 0.00 (-0.73%)

As of 07/3/2025 12:06 PM Eastern

Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.

OrthoPediatrics NASDAQ:KIDS

$22.46 +0.33 (+1.47%)

Closing price 07/3/2025 03:24 PM Eastern

Extended Trading

$22.13 -0.34 (-1.49%)

As of 04:10 AM Eastern

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

Orthofix Medical NASDAQ:OFIX

$11.12 +0.07 (+0.59%)

Closing price 07/3/2025 01:01 PM Eastern

Extended Trading

$10.96 -0.16 (-1.44%)

As of 07:00 AM Eastern

Orthofix Medical Inc. operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations. The Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.

Westaim OTCMKTS:WEDXF

$22.75 +0.08 (+0.36%)

As of 07/3/2025 12:59 PM Eastern

The Westaim Corporation is a private equity firm specializing in direct and indirect investments through acquisitions, joint ventures, secondary investments both direct and indirect, fund of fund investments, and other arrangements. For direct investments, the firm invests in early venture, mid venture, late venture, middle market, later stage, mature, emerging growth, PIPEs, and buyout transactions. For fund of fund investments, it seeks to invest in private equity funds, venture capital funds, and hedge funds. The firm seeks to provide long term capital to businesses operating in the global financial services industry. It typically acquires controlling interests in businesses. The firm seeks to acquire debt, equity, or derivative securities of both public and private companies. It invests with the objective of providing its shareholders with capital appreciation and real wealth preservation. The firm seeks to provide its portfolio companies with advisory services including, but not limited to, advice on capital allocation, financing strategy, performance measurement and merger and acquisition support. It also seeks to partner with like-minded providers of third party capital to help supplement the firm's own capital, when completing acquisitions. The firm generally seeks to hold its investments for seven to 15 years. The Westaim Corporation was founded in 1996 and is based in Toronto, Canada.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time